Biblio

Author [ Keyword(Desc)] Title Type Year
Filters: Author is Bilsland, Alan  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
Adenocarcinoma
Dufès C, W Keith N, Bilsland A, Proutski I, Uchegbu IF, Schätzlein AG.  2005.  Synthetic anticancer gene medicine exploits intrinsic antitumor activity of cationic vector to cure established tumors.. Cancer Res. 65(18):8079-84.
Animals
Dufès C, W Keith N, Bilsland A, Proutski I, Uchegbu IF, Schätzlein AG.  2005.  Synthetic anticancer gene medicine exploits intrinsic antitumor activity of cationic vector to cure established tumors.. Cancer Res. 65(18):8079-84.
Carcinoma, Squamous Cell
Dufès C, W Keith N, Bilsland A, Proutski I, Uchegbu IF, Schätzlein AG.  2005.  Synthetic anticancer gene medicine exploits intrinsic antitumor activity of cationic vector to cure established tumors.. Cancer Res. 65(18):8079-84.
Cell Line, Tumor
Dufès C, W Keith N, Bilsland A, Proutski I, Uchegbu IF, Schätzlein AG.  2005.  Synthetic anticancer gene medicine exploits intrinsic antitumor activity of cationic vector to cure established tumors.. Cancer Res. 65(18):8079-84.
Colorectal Neoplasms
Dufès C, W Keith N, Bilsland A, Proutski I, Uchegbu IF, Schätzlein AG.  2005.  Synthetic anticancer gene medicine exploits intrinsic antitumor activity of cationic vector to cure established tumors.. Cancer Res. 65(18):8079-84.
Female
Dufès C, W Keith N, Bilsland A, Proutski I, Uchegbu IF, Schätzlein AG.  2005.  Synthetic anticancer gene medicine exploits intrinsic antitumor activity of cationic vector to cure established tumors.. Cancer Res. 65(18):8079-84.
Genetic Therapy
Dufès C, W Keith N, Bilsland A, Proutski I, Uchegbu IF, Schätzlein AG.  2005.  Synthetic anticancer gene medicine exploits intrinsic antitumor activity of cationic vector to cure established tumors.. Cancer Res. 65(18):8079-84.
Genetic Vectors
Dufès C, W Keith N, Bilsland A, Proutski I, Uchegbu IF, Schätzlein AG.  2005.  Synthetic anticancer gene medicine exploits intrinsic antitumor activity of cationic vector to cure established tumors.. Cancer Res. 65(18):8079-84.
Humans
Dufès C, W Keith N, Bilsland A, Proutski I, Uchegbu IF, Schätzlein AG.  2005.  Synthetic anticancer gene medicine exploits intrinsic antitumor activity of cationic vector to cure established tumors.. Cancer Res. 65(18):8079-84.
Lac Operon
Dufès C, W Keith N, Bilsland A, Proutski I, Uchegbu IF, Schätzlein AG.  2005.  Synthetic anticancer gene medicine exploits intrinsic antitumor activity of cationic vector to cure established tumors.. Cancer Res. 65(18):8079-84.
Nanostructures
Dufès C, W Keith N, Bilsland A, Proutski I, Uchegbu IF, Schätzlein AG.  2005.  Synthetic anticancer gene medicine exploits intrinsic antitumor activity of cationic vector to cure established tumors.. Cancer Res. 65(18):8079-84.
Neoplasms
Dufès C, W Keith N, Bilsland A, Proutski I, Uchegbu IF, Schätzlein AG.  2005.  Synthetic anticancer gene medicine exploits intrinsic antitumor activity of cationic vector to cure established tumors.. Cancer Res. 65(18):8079-84.
Plasmids
Dufès C, W Keith N, Bilsland A, Proutski I, Uchegbu IF, Schätzlein AG.  2005.  Synthetic anticancer gene medicine exploits intrinsic antitumor activity of cationic vector to cure established tumors.. Cancer Res. 65(18):8079-84.
Polypropylenes
Dufès C, W Keith N, Bilsland A, Proutski I, Uchegbu IF, Schätzlein AG.  2005.  Synthetic anticancer gene medicine exploits intrinsic antitumor activity of cationic vector to cure established tumors.. Cancer Res. 65(18):8079-84.
Promoter Regions, Genetic
Dufès C, W Keith N, Bilsland A, Proutski I, Uchegbu IF, Schätzlein AG.  2005.  Synthetic anticancer gene medicine exploits intrinsic antitumor activity of cationic vector to cure established tumors.. Cancer Res. 65(18):8079-84.
Transfection
Dufès C, W Keith N, Bilsland A, Proutski I, Uchegbu IF, Schätzlein AG.  2005.  Synthetic anticancer gene medicine exploits intrinsic antitumor activity of cationic vector to cure established tumors.. Cancer Res. 65(18):8079-84.
Tumor Necrosis Factor-alpha
Dufès C, W Keith N, Bilsland A, Proutski I, Uchegbu IF, Schätzlein AG.  2005.  Synthetic anticancer gene medicine exploits intrinsic antitumor activity of cationic vector to cure established tumors.. Cancer Res. 65(18):8079-84.
Uterine Cervical Neoplasms
Dufès C, W Keith N, Bilsland A, Proutski I, Uchegbu IF, Schätzlein AG.  2005.  Synthetic anticancer gene medicine exploits intrinsic antitumor activity of cationic vector to cure established tumors.. Cancer Res. 65(18):8079-84.
Xenograft Model Antitumor Assays
Dufès C, W Keith N, Bilsland A, Proutski I, Uchegbu IF, Schätzlein AG.  2005.  Synthetic anticancer gene medicine exploits intrinsic antitumor activity of cationic vector to cure established tumors.. Cancer Res. 65(18):8079-84.